+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Ablation Devices - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 81 Pages
  • March 2021
  • Region: Global
  • GlobalData
  • ID: 5310566
The publisher's Medical Devices sector report, “Cardiac Ablation Devices - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Cardiac Ablation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Ablation Devices are devices that use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Ablation Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Ablation Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Ablation Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Cardiac Ablation Devices Overview
3 Products under Development
3.1 Cardiac Ablation Devices - Pipeline Products by Stage of Development
3.2 Cardiac Ablation Devices - Pipeline Products by Territory
3.3 Cardiac Ablation Devices - Pipeline Products by Regulatory Path
3.4 Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
3.5 Cardiac Ablation Devices - Ongoing Clinical Trials
4 Cardiac Ablation Devices - Pipeline Products under Development by Companies
4.1 Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
4.2 Cardiac Ablation Devices - Pipeline Products by Stage of Development
5 Cardiac Ablation Devices Companies and Product Overview
5.1 AblaCor Medical Corporation Company Overview
5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adagio Medical Inc. Company Overview
5.2.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 AFreeze GmbH Company Overview
5.3.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.4 AngioDynamics Inc Company Overview
5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Atrian Medical Ltd Company Overview
5.5.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 AtriCure Inc Company Overview
5.6.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Axon Therapies Inc Company Overview
5.7.1 Axon Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Baylis Medical Company Inc Company Overview
5.8.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Corfigo Inc Company Overview
5.9.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Coridea, LLC Company Overview
5.10.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 CPSI Biotech Company Overview
5.11.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
5.12 Ethicon US LLC Company Overview
5.12.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
5.13 Farapulse Inc Company Overview
5.13.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Galaxy Medical Products Inc Company Overview
5.14.1 Galaxy Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Helical Solutions, Inc. (Inactive) Company Overview
5.15.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.16 Johns Hopkins University Company Overview
5.16.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.17 Kardium Inc Company Overview
5.17.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 LuxCath, LLC Company Overview
5.18.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.19 Medtronic Plc Company Overview
5.19.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Northwestern University Company Overview
5.20.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.21 Sheba Medical Center Company Overview
5.21.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.22 Spectranetics Corp Company Overview
5.22.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Thermedical Inc Company Overview
5.23.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Toray Medical Co Ltd Company Overview
5.24.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Tufts Medical Center Company Overview
5.25.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.26 University of California Los Angeles Company Overview
5.26.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.27 University of Chicago Company Overview
5.27.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.28 VytronUS Inc Company Overview
5.28.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Cardiac Ablation Devices- Recent Developments
6.1 Mar 01, 2021: AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
6.2 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.3 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.4 Feb 10, 2021: AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference
6.5 Feb 04, 2021: Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
6.6 Feb 02, 2021: AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results
6.7 May 07, 2020: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2020
6.8 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • Cardiac Ablation Devices - Pipeline Products by Territory
  • Cardiac Ablation Devices - Pipeline Products by Regulatory Path
  • Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
  • Cardiac Ablation Devices - Ongoing Clinical Trials
  • Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
  • Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • AutoBlator - Product Status
  • AutoBlator - Product Description
  • CircumBlator AF Catheter Ablation System - Product Status
  • CircumBlator AF Catheter Ablation System - Product Description
  • Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • iCLAS System - Product Status
  • iCLAS System - Product Description
  • Adagio Medical Inc. - Ongoing Clinical Trials Overview
  • iCLAS System - A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients with Atrial Fibrillation
  • iCLAS System - iCLAS for Persistent Atrial Fibrillation
  • AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Tip-Catheter - Product Status
  • Tip-Catheter - Product Description
  • AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Non-Thermal Vein Ablation Device - Product Status
  • Non-Thermal Vein Ablation Device - Product Description
  • Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • mPEF Device - Atrial Fibrillation - Product Status
  • mPEF Device - Atrial Fibrillation - Product Description
  • AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
  • AtriCure Bipolar System - Product Status
  • AtriCure Bipolar System - Product Description
  • EPi-Sense - Long Standing Persistent AF - Product Status
  • EPi-Sense - Long Standing Persistent AF - Product Description
  • Isolator Synergy Encompass Clamp - Product Status
  • Isolator Synergy Encompass Clamp - Product Description
  • AtriCure Inc - Ongoing Clinical Trials Overview
  • AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
  • Axon Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Satera Ablation System - Product Status
  • Satera Ablation System - Product Description
  • Axon Therapies Inc - Ongoing Clinical Trials Overview
  • Satera Ablation System - Endovascular Ablation of the Right Greater Splanchnic Nerve in Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects having HFpEF: Feasibility Study: Randomized Controlled Feasibility Trial- Rebalance-HF Study
  • Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Cardiac Ablation Mitigating Device - Product Status
  • Cardiac Ablation Mitigating Device - Product Description
  • Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview
  • HeArTPAD - Product Status
  • HeArTPAD - Product Description
  • Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Cardiac Sympathetic Denervation Device - Product Status
  • Cardiac Sympathetic Denervation Device - Product Description
  • CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
  • ICEolate Catheter - Product Status
  • ICEolate Catheter - Product Description
  • ICEolate Catheter With Spot Ablation Tip - Product Status
  • ICEolate Catheter With Spot Ablation Tip - Product Description
  • ICEolate Surgical Probe With Control Handle - Product Status
  • ICEolate Surgical Probe With Control Handle - Product Description
  • ICEolate Surgical Probe With Flexible Ablation Tip - Product Status
  • ICEolate Surgical Probe With Flexible Ablation Tip - Product Description
  • Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Next Generation Ablation Catheter - Product Status
  • Next Generation Ablation Catheter - Product Description
  • Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Pulsed Field Ablation System - Product Status
  • Pulsed Field Ablation System - Product Description
  • Farapulse Inc - Ongoing Clinical Trials Overview
  • Pulsed Field Ablation System - A Prospective Randomized Pivotal Trial of the FARAPULSE Pulsed Field Ablation System Compared with Standard of Care Ablation in Patients with Paroxysmal Atrial Fibrillation
  • Galaxy Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Centauri System - Product Status
  • Centauri System - Product Description
  • Galaxy Medical Products Inc - Ongoing Clinical Trials Overview
  • Centauri System - Study Evaluating the Safety and Efficacy of the Centauri system
  • Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Catheter-Based Ablation Device - Product Status
  • Catheter-Based Ablation Device - Product Description
  • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Catheter Guiding Computational Modeling Tool - Product Status
  • Catheter Guiding Computational Modeling Tool - Product Description
  • Oscillatory Atherectomy Device - Product Status
  • Oscillatory Atherectomy Device - Product Description
  • Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
  • CHS - Coated Globe Mapping And Ablation System - Product Status
  • CHS - Coated Globe Mapping And Ablation System - Product Description
  • Globe Mapping And Ablation System - Product Status
  • Globe Mapping And Ablation System - Product Description
  • Kardium Inc - Ongoing Clinical Trials Overview
  • Globe Mapping And Ablation System - A Prospective, Non-randomized Clinical Study to Assess the Performance of the Globe Positioning System for Left Atrial Mapping During Cardiac Ablation for the Treatment of Atrial Fibrillation
  • LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • OmniView Light-Guided Ablation Catheter - Product Status
  • OmniView Light-Guided Ablation Catheter - Product Description
  • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Cardioblate Irrigated RF (IRF) System - Non-Paroxysmal Atrial Fibrillation - Product Status
  • Cardioblate Irrigated RF (IRF) System - Non-Paroxysmal Atrial Fibrillation - Product Description
  • CryoFlex Surgical Ablation System - Non-Paroxysmal Atrial Fibrillation - Product Status
  • CryoFlex Surgical Ablation System - Non-Paroxysmal Atrial Fibrillation - Product Description
  • PulseSelect PFA System - Product Status
  • PulseSelect PFA System - Product Description
  • Medtronic Plc - Ongoing Clinical Trials Overview
  • Cardioblate Irrigated RF (IRF) System - Non-Paroxysmal Atrial Fibrillation - Irrigated Radio Frequency Ablation to Terminate Non-paroxysmal Atrial Fibrillation: Terminate AF Study
  • PulseSelect PFA System - Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
  • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • Cardiac Tissue Ablation Device - Product Status
  • Cardiac Tissue Ablation Device - Product Description
  • Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Transcatheter Septal Myectomy Device - Product Status
  • Transcatheter Septal Myectomy Device - Product Description
  • Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Nexcimer - Product Status
  • Nexcimer - Product Description
  • Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Durablate Ablation Catheter - Product Status
  • Durablate Ablation Catheter - Product Description
  • Thermedical Inc - Ongoing Clinical Trials Overview
  • Durablate Ablation Catheter - Saline Enhanced Radiofrequency (SERF) VT Ablation Early Feasibility Study (EFS)
  • Durablate Ablation Catheter - Saline-enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia
  • Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • SATAKE HotBalloon Catheter - Product Status
  • SATAKE HotBalloon Catheter - Product Description
  • Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Tissue Ablation Device - Product Status
  • Tissue Ablation Device - Product Description
  • University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • Cryogenic Anchor - Product Status
  • Cryogenic Anchor - Product Description
  • University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • DVT Histotripsy System - Product Status
  • DVT Histotripsy System - Product Description
  • VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System - Product Status
  • Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System - Product Description
  • VytronUS Inc - Ongoing Clinical Trials Overview
  • Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System - Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation
  • Low-Intensity Collimated Ultrasound (LICU) Cardiac Mapping and Ablation System - Early Feasibility Study of Automated Ultrasound Technology for the Treatment of Persistent Atrial Fibrillation
  • Glossary

List of Figures
  • Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • Cardiac Ablation Devices - Pipeline Products by Territory
  • Cardiac Ablation Devices - Pipeline Products by Regulatory Path
  • Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
  • Cardiac Ablation Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AblaCor Medical Corporation
  • Adagio Medical Inc.
  • AFreeze GmbH
  • AngioDynamics Inc
  • Atrian Medical Ltd
  • AtriCure Inc
  • Axon Therapies Inc
  • Baylis Medical Company Inc
  • Corfigo Inc
  • Coridea, LLC
  • CPSI Biotech
  • Ethicon US LLC
  • Farapulse Inc
  • Galaxy Medical Products Inc
  • Helical Solutions, Inc. (Inactive)
  • Johns Hopkins University
  • Kardium Inc
  • LuxCath, LLC
  • Medtronic Plc
  • Northwestern University
  • Sheba Medical Center
  • Spectranetics Corp
  • Thermedical Inc
  • Toray Medical Co Ltd
  • Tufts Medical Center
  • University of California Los Angeles
  • University of Chicago
  • VytronUS Inc